The chairman of Diamond Biofund Inc. and Microbio group, William Lu announced the official listing plan of its invested enterprises on July 4th, starting with the biggest new drugs platform of new generation antibody immunotherapy, CHO PHARMA Inc., the joint venture biotech company invested by Academia Sinica, Ruentex Group and Microbio group.

There are many promising biotech companies under the Microbio group, one of its subsidiary companies, Diamond Biofund Inc. invest several innovative biotech companies, including anti-cancer immunotherapy by CHO PHARMA Inc., new drug development by Sun Biofund Inc., innovative medical instruments by Iridium Medical Technology, will all reveal this year to let the world know the R&D capability of Taiwan’s biotechnology.